Yale Cancer Center

https://www.yalecancercenter.org/

 

ecancer
Avatar

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysis of Adjuvant Osimertinib in Patients With Resected EGFRm Stage IB–IIIA NSCLC"

By ecancer FEATURING Roy Herbst
By ecancer FEATURING Roy Herbst
432 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Lung
10:19

Using Biomarkers in Clinical Management of Patients With ES-SCLC

Yale Cancer Center

A. Chiang

207 views
13:21

Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanc…

Yale Cancer Center

A. Nassar

490 views
09:28

The Future of Lung Cancer Care

Yale Cancer Center

M. Davies

576 views
20:27

Progress in the Treatment of NSCLC

Yale Cancer Center

R. Herbst

509 views
19:16

Treatment Approach to ROS1 Rearranged NSCLC

Yale Cancer Center

M. Grant

528 views
14:45

KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity,…

Yale Cancer Center

A. Nassar

223 views
01:42

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysis of …

ecancer

R. Herbst

432 views
12:40

Consolidation IO Following CRT in Stage III NSCLC

Yale Cancer Center

H. Park

257 views
35:51

Advancements in NSCLC: Multidisciplinary Case Panel Discussion

Yale Cancer Center

S. Benaderet, M. Cohenuram, S. Goldberg, V. Mase Jr, D. Rudolph

246 views
13:44

Yale Cancer Center on Lung Cancer Screening

Yale Cancer Center

J. Blasberg

204 views
14:27

Yale Cancer Center on Lung Cancer Screening: Nurse Perspective

Yale Cancer Center

E. Kopas

88 views
10:02
i3 Health

2021 ES-SCLC Updates: Enhancing the Clinical Outcomes With Novel The…

Feat. A. Chiang
09:41

2020 Advances in Lung Cancer: What Are the Biggest NSCLC IO Advantag…

Yale Cancer Center

A. Chiang

51 views
07:08

Advances in Targeted Therapy for NSCLC: What Is the Importance of Bi…

Yale Cancer Center

A. Chiang

269 views
14:03

ESMO 2019 Updated IMpower110 Trial Results: With Consistent OS/PFS I…

Yale Cancer Center

R. Herbst

1.7K views